|
Annel J. Rho GTPase and cell migration . Journal of Cell Science 2001;114: 2713-2722. Bajzar L, Neshein M, Morser J . Both cellular and soluble form of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor. J Biol Chem 2000;275:2792-798. Berridge MJ, Inositol trisphosphate and and diacylglycerol: Two interacting second messengers. Annu Rev Biochem 1987;56:159-193. Burgering BMT, Coffer PJ. Protein kinase B (c-akt) in phosphatidylinositol 3-kinase signal transduction. Nature 1995;376:599-602. Babich M, King KL, Nissenson RA. Thrombin stimulates inositol phosphate production and intracellular free calcium by a pertussis toxin –insensitive mechanism in osteosarcoma cells . Endocrinology 1990;126:948-954. Cirino G, Cicala C, Bucci M, Sorrentino L, Maraganore J, Stone SR. Thrombin functions as an inflammatory mediator through activation of its receptor. J Exp Med 1996;183:821-827. Coughlin SR. Thrombin signaling and protease - activated receptors. Nature 2000; 407:258-264. Coughlin SR. How the protease thrombin talks to cells . Proc Natl Acad Sci USA 1999;96:11023-11027. Corbit KC, Trakul N, Eves EM, Diaz B, Marshall M, Rosner MR. Activation of Raf-1 Signaling by Protein Kinase C through a Mechanism Involving Raf Kinase Inhibitory Protein. J Biol Chem 2003;278:13061-13068. Collins LR, Ricketts WA, Olefsky JM ,Brown JH. The G12 coupled thrombin receptor stimulates mitogenesis through the Shc SH2 domain. Oncogene 1997;15:595-600. Dahlback B . Progress in the understanding of the understanding of the protein C anticoagulant pethway . Int J Hematol 2004;79:109-116.Dery O, Corvera CU, Steinhoff M, Bunnett NW. Protease activated receptors : novel mechanisms of signaling by serine protease. Am J Physiol 1998;274:1429-1452. David-Dufilho M, Brussel EMV, Topal G, Walch L, Brunet A, and Rendu F. Endothelial Thrombomodulin Induces Ca2+ Signals and Nitric Oxide Synthesis through Epidermal Growth Factor Receptor Kinase and Calmodulin Kinase II . J Biol Chem 2005;280:35999-36006. Dittman WA, Majerus PW. Structure and function of thrombomodulin: a natural anticoagulant. Blood 1990;75:329-336. Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin -catalyzed activation of protein C. Proc Natl Acad Sci USA 1981;78:2249-2252. Esmon CT. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. The FASEB Journal 1995; 9:946-955. Esmon, C. T. The protein C pathway. Chest 2003;124:26S-32S. Esmon CT. Introduction: are natural anticoagulant candidates for modulating the inflammatory response to endotoxin. Blood 2000;95:1113-1116. Faioni EM, Franchi F, Castaman G, Biguzzi E, Rodeghiero F. Mutations in the thrombomodulin gene are rare in patients with severe thrombophilia.Br J Haematol 2002;118:595-599. Frank TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR, Tsichlis PN. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF activated phosphatidylinositol 3-kinase. Cell 1995;81:727-736. Freedman JE. Thrombin, Thrombomodulin, and Extracellular Signal–Regulated Kinases Regulating Cellular Proliferation. Circ Res 2001;88;651-653 Grinnell B, Berg D. Surface thrombomodulin modulates thrombin receptor responses on vascular smooth muscle cells. Am J Physiol 1996;270:603-609. Gabius HJ. Concepts of Tumor Lectinology . J Cancer Investig 1997;15:454-464. Grand RJ, Turnell AS, Grabham PW. Cellular consequences of thrombin-receptor activation. Biochem J 1996;313:353-368. Guha A, Feldkamp MM, Lau N, Boss G, Pawson A. Proliferation of human malignant astrocytomas is dependent on Ras activation . oncogene 1997;15:2755-2765. Gerszten RE, Chen J, Ishii M, Ishii K, Wang L, Nanevicz T, Turck CW,Vu TK, Coughlin SR. Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface. Nature 1994;368:648-651. Hattori R, Hamilton kk, Fugate RD, McEver RP, Sims PJ. Stimulated secretion of endothelial vWF is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J Biol Chem 1989;264:7768-7771. Hamilton JR, Nguyen PB, Cocks TM. Atypical protease-activated receptor mediates endothelium-dependent relaxation of human coronary arteries. Circ Res 1998;82:1306-1311. Hosaka Y, Higuchi T, Tsumagari M, Ishii H. Inhibition of invasion and experimental metastasis of murine melanoma cells by human soluble thrombomodulin. Cancer Lett 2000;161:231-240. Isermann B, Hendrickson SB, Zogg M, Wing M, Cunmmiskey M, Kisanuki YY. Endothelium -specific loss of murine throbomodulin disrupts the protein C anticoagulant pathway and causes juvenile-onset thrombosis . J Clin Invest 2001;108:537-546. Ireland H, Kunz G, Kyriakoulis K, Stubbs PJ, Lane DA. Thrombomodulin gene mutations associated with myocardial infarction. Circulation 1997;96:15-8. Kaplanski G, Marin V, Fabrigoule M, Boulay V, Benoliel AM, Bongrand P, Kaplanski S, Farnarier C. Thrombin-activated human endothelial cells support monocyte adhesion in vitro following expression of intercellular adhesion molecule-1 (ICAM- 1; CD54) and vascular cell adhesion molecule-1 (VCAM-1; CD106). Blood 1998;92:1259-1267. Koyama T, Parkinson JF, Aoki N , Bang NU , Muller- Berghaus G, Preissner KT , Relationship between post translational glycosylation and anticoagulant function of secretable recombinant mutants of human thrombomodulin , British J Hameatol 1991;78:515-522. Klages B, Brandt U, Simon MI, Schultz G, Offermanns S. Activation of G12/G13 results in shape change and rho/rho kinase-mediated myosin light chain phosphorylation in mouse platelets. J Cell Biol 1999;144:745-754. Khosravi-Far R, Der CJ, The Ras signal transduction pathway .Cancer Metastasis Rev 1994;13:67-89. Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001;81:807-869. Khwaja A, Rodriguez-Viciana P, Wennstrom S, Warn PH, Downward J .Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J 1997;16:2783-2793. King WG, Mattaliano MD, Chan TO, Tsichlis PN, Brugge JS.Phosphatidylinositol 3-kinase is required for integrinstimulated AKT and Raf-1/mitogen-activatad protein kinase pathway activation. Mol Cell Biol 1997;17:4406-4418. Light DR, Glaser CB, Betts M, Blasko E, Campbell E, Clarke JH, McCaman M, McLean K, Nagashima M, Parkinson JF, Rumennik G, Young T, Morser J. The interaction of thrombomodulin with Ca2 +. Eur J Biochem 1999;262:522-533. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW.A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994;372:739-746. Lafay M, Laguna R, Le Bonniec BF, Lasne D, Aiach M, Rendu F. Thrombomodulin modulates the mitogenic response to thrombin of human umbilical vein endothelial cells. Thromb Haemost 1998;79:848-852. Maragoudakis ME, Tsopanoglou NE. On the mechanism(s) of thrombin induced angiogenesis. Adv Exp Med Biol 2000;476:47-55. Macfarlane SR, Seatter MJ, Kanke TV . Proteinase-activated receptors. Pharmacol Rev 2001;53:245-282. Marshall C. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-related kinase activation. Cell 1995;80:179-185. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature 1984;308:693-698. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids andactivation of protein kinase . FASEB J 1995;9:484-496. Offermanns S, Toombs CF, Hu YH, Simon MI. Defective platelet activation in Gαq-deficientmice. Nature 1997;389:183-186. Offermanns S, Mancino V, Revel JP, Simon M I. Vascular system defects and impaired cell chemokinesis as a result of Gα13 deficiency. Science 1997;275:533-536. Ogawa H, Yonezawa S, Maruyama I, Matsushita Y, Tezuka Y, Toyoyama H, Yanagi M, Matsumoto H, Nishijima H, Shimotakahara T, Aikou T, Sato, E . Cancer Lett 2000;149:95-103. Olivot JM, Estebanell E, Lafay M, Brohard B, Aiach M, Rendu F. Thrombomodulin Prolongs Thrombin-Induced Extracellular Signal–Regulated Kinase Phosphorylation and Nuclear Retention in Endothelial Cells . Circ Res 2001;88:681-687. Pankonin G, Teuscher E. Stimulation of endothelial cell migration by thrombin. Biomed Biochim Acta 1991;50:1073-1078. Rabiet MJ, Plantier JL, Rival Y, Genoux Y, Lampugnani MG, Dejana E, Thrombin -induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization. Arterioscler Thromb Vasc Biol 1996;16:488-496. Sakharov DV, Plow EF, Rijken DC. On the mechanism of the antifibrinolytic activity of plasma carboxypeptidase B. J Biol Chem 1997;272:14477-14482. Sadler JE. Thrombomodulin structure and function. Thromb. Haemostasis 1997; 78:392-395. Schönwasser DC, Marais RM, Marshall CJ, Parker PJ .Activation of the Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Pathway by Conventional, Novel, and Atypical Protein Kinase C Isotypes. Mol Cell Biol 1998;18:790-798. Tsopanoglou NE, Maragoudakis ME. On the mechanism of thrombininduced angiogenesis: potentiation of vascular endothelial growth factor activity on endothelial cells by up-regulation of its receptors. J Biol Chem 1999;274:23969-23976. Taussig R , Gilman AG . Mammalian Membrane-bound Adenylyl Cyclases . J Biol Chem 1995;270:1-4. Van de Wouwer M , Collen D , Coway EM . Thrombomodulin protein C-EPCR system : integrated to regulate coagulation and inflammation . Arterioscler Thromb Vasc Biol 2004;24:1374-83. Vouret-Craviari V, Boquet P, Pouysségur J, Van Obberghen-Schilling E. Regulation of the actin cytoskeleton by thrombin in human endothelial cells: role of Rho proteins in endothelial barrier function. Mol Biol Cell 1998;9:2639-2653. Vanhaesebroeck B, Alessi DR. The PI3K–PDK1 connection : more than just a road to PKB . Biochem J 2000;346:561-76. Wang J, Morita I, Onodera M, Murota SI. Induction of KDR expression in bovine arterial endothelial cells by thrombin: involvement of nitric oxide. J Cell Physiol 2002;190:238-250. Wang W, Boffa MB, Bajzar L, Walker JB, Neisheim ME. A study of the mechanism of inhibition of fibrinolysis by activated thrombin activable fibrinolysis inhibitor. J Biol Chem 1998;273:27176-27181. Wu KK, Matijevic-Aleksic N. Thrombomodulin: a linker of coagulation and fibrinolysis and predictor of risk of arterial thrombosis. Ann Med 2000;32:73-77. Weiler H, Isermann, BH. Thrombomodulin. J Thromb Haemost 2003;1:1515-1524. Wang Z, Canagarajah BJ . Structural basis of inhibitor selectivity in MAP kinase. Structure 1998;6:1117-1128. Walker TR, Moore SM, Lawson MF, Panettieri JrRA, R ,CE . Platelet derived growth factor BB and thrombin activate phosphoinositide 3-kinase and protein kinase B : Role in mediating airway smooth muscle proliferation. Mol Pharmacol 1998;54:1007-1015. Xue M, Thompson P, Kelso I, Jackson C. Activated protein C stimulates proliferation, migration and wound closure, inhibits apoptosis and upregulates MMP-2 activity in cultured human keratinocytes. Exp Cell Res 2004;299:119-127. Zhang Y, Weiler-Guettler H, Chen J, Wilhelm O, Deng Y, Qiu F, Nakagawa K, Klevesath M, Wilhelm S, Bohrer H, Nakagawa M, Graeff H, Martin E, Stern DM, Rosenberg RD, Ziegler R, Nawroth PP. Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity. J Clin Invest 1998;101:1301-1309.
|